Furthermore, FGFR3 activation of the MAPK cascade, albeit in the context of multiple myeloma, has been shown to block the promoter function, expression, and secretion of the chemokine CCL3 (108), linking both SOCS1 and FGFR3 to the modulation of the chemokine response. This evidence concerns the gene CCL3 and AL amyloidosis.